Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Sep;73(3):389–394.

Immunoglobulin synthesis in primary and myeloma amyloidosis.

J L Preud'homme 1, D Ganeval 1, J P Grünfeld 1, L Striker 1, J C Brouet 1
PMCID: PMC1541772  PMID: 3145161

Abstract

Bone marrow cells from 14 patients with primary amyloidosis and two patients with myeloma amyloidosis were studied by immunofluorescence and biosynthesis experiments after incorporation of radioactive amino acids. Cells from four patients affected with non-myeloma secondary amyloidosis were also studied as controls. In primary amyloidosis, monoclonal plasma cell populations were demonstrated by immunofluorescence in virtually every case, even in patients without serum and urine monoclonal immunoglobulin and with a normal percentage of bone marrow plasma cells. Biosynthesis experiments showed the secretion of large amounts of free light chains, most often of the lambda type, in every primary or myeloma amyloidosis case and the presence of light chain fragments in almost all cases. Special features in certain patients were the synthesis of short gamma chains (two cases), assembly block at the HL half molecule level of a monoclonal IgA (one case) and secretion of decameric abnormally large kappa chains (one case). This is in contrast with non-myelomatous secondary amyloidosis where the distribution of bone marrow plasma cells was normal by immunofluorescence and where normal sized immunoglobulins were synthesized, without free light chain secretion and fragments. These data confirm that primary amyloidosis belongs to plasma cell dyscrasias and emphasize the role of free light chains and light chain fragments in the pathogenesis of amyloid deposition.

Full text

PDF
389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azar H. A., Zaino E. C., Pham T. D., Yannopoulos K. "Nonsecretory" plasma cell myeloma: observations on seven cases with electron microscopic studies. Am J Clin Pathol. 1972 Dec;58(6):618–629. doi: 10.1093/ajcp/58.6.618. [DOI] [PubMed] [Google Scholar]
  2. Buxbaum J. N., Hurley M. E., Chuba J., Spiro T. Amyloidosis of the AL type. Clinical, morphologic and biochemical aspects of the response to therapy with alkylating agents and prednisone. Am J Med. 1979 Nov;67(5):867–878. doi: 10.1016/0002-9343(79)90747-2. [DOI] [PubMed] [Google Scholar]
  3. Buxbaum J. Aberrant immunoglobulin synthesis in light chain amyloidosis. Free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture. J Clin Invest. 1986 Sep;78(3):798–806. doi: 10.1172/JCI112643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Durie B. G., Persky B., Soehnlen B. J., Grogan T. M., Salmon S. E. Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages. N Engl J Med. 1982 Dec 30;307(27):1689–1692. doi: 10.1056/NEJM198212303072706. [DOI] [PubMed] [Google Scholar]
  5. Epstein W. V., Tan M., Wood I. S. Formation of "amyloid" fibrils in vitro by action of human kidney lysosomal enzymes on Bence Jones proteins. J Lab Clin Med. 1974 Jul;84(1):107–110. [PubMed] [Google Scholar]
  6. Gallo G. R., Feiner H. D., Katz L. A., Feldman G. M., Correa E. B., Chuba J. V., Buxbaum J. N. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis. Am J Pathol. 1980 Jun;99(3):621–644. [PMC free article] [PubMed] [Google Scholar]
  7. Glenner G. G. Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts). N Engl J Med. 1980 Jun 12;302(24):1333–1343. doi: 10.1056/NEJM198006123022403. [DOI] [PubMed] [Google Scholar]
  8. Glenner G. G., Ein D., Eanes E. D., Bladen H. A., Terry W., Page D. L. Creation of "amyloid" fibrils from Bence Jones proteins in vitro. Science. 1971 Nov 12;174(4010):712–714. doi: 10.1126/science.174.4010.712. [DOI] [PubMed] [Google Scholar]
  9. Jacquot C., Saint-Andre J. P., Touchard G., Nochy D., D'Auzac de Lamartinie C., Oriol R., Druet P., Bariety J. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement. Clin Nephrol. 1985 Aug;24(2):93–98. [PubMed] [Google Scholar]
  10. Linke R. P., Tischendorf F. W., Zucker-Franklin D., Franklin E. C. The formation of amyloid-like fibrils in vitro from Bence Jones Proteins of the VlambdaI subclass. J Immunol. 1973 Jul;111(1):24–26. [PubMed] [Google Scholar]
  11. Preud'Homme J. L., Birshtein B. K., Scharff M. D. Variants of a mouse myeloma cell line that synthesize immunoglobulin heavy chains having an altered serotype. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1427–1430. doi: 10.1073/pnas.72.4.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Preud'Homme J. L., Hurez D., Danon F., Brouet J. C., Seligmann M. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma. Clin Exp Immunol. 1976 Sep;25(3):428–436. [PMC free article] [PubMed] [Google Scholar]
  13. Preud'Homme J. L., Morel-Maroger L., Brouet J. C., Mihaesco E., Mery J. P., Seligmann M. Synthesis of abnormal heavy and light chains in multiple myeloma with visceral deposition of monoclonal immunoglobulin. Clin Exp Immunol. 1980 Dec;42(3):545–553. [PMC free article] [PubMed] [Google Scholar]
  14. Preud'homme J. L., Klein M., Labaume S., Seligmann M. Idiotype-bearing and antigen-binding receptors produced by blood T lymphocytes in a case of human myeloma. Eur J Immunol. 1977 Dec;7(12):840–846. doi: 10.1002/eji.1830071204. [DOI] [PubMed] [Google Scholar]
  15. Preud'homme J. L., Labaume S., Praloran V. Synthesis of abnormal heavy chains in Bence-Jones plasma cell leukemia with intracellular IgG. Blood. 1980 Dec;56(6):1136–1140. [PubMed] [Google Scholar]
  16. Preud'homme J. L., Mihaesco E., Guglielmi P., Morel-Maroger L., Ganeval D., Danon F., Brouet J. C., Mihaesco C., Seligmann M. La maladie des dépôts de chaînes légères ou d'immunoglobulines monoclonales: concepts physiopathogéniques. Nouv Presse Med. 1982 Nov 6;11(44):3259–3263. [PubMed] [Google Scholar]
  17. Preud'homme J. L., Morel-Maroger L., Brouet J. C., Cerf M., Mignon F., Guglielmi P., Seligmann M. Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition. Am J Med. 1980 Nov;69(5):703–710. doi: 10.1016/0002-9343(80)90421-0. [DOI] [PubMed] [Google Scholar]
  18. Randall R. E., Williamson W. C., Jr, Mullinax F., Tung M. Y., Still W. J. Manifestations of systemic light chain deposition. Am J Med. 1976 Feb;60(2):293–299. doi: 10.1016/0002-9343(76)90440-x. [DOI] [PubMed] [Google Scholar]
  19. Zolla S., Buxbaum J., Franklin E. C., Scharff M. D. Synthesis and assembly of immunoglobulins by malignant human plasmacytes. I. Myelomas producing gamma-chains and light chains. J Exp Med. 1970 Jul 1;132(1):148–162. doi: 10.1084/jem.132.1.148. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES